ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "polymyalgia rheumatica and regulatory cells"

  • Abstract Number: 1956 • 2014 ACR/ARHP Annual Meeting

    Increased IL-6 Production By Effector B Cells in Giant Cell Arteritis and Polymyalgia Rheumatica

    Kornelis S.M. van der Geest1, Wayel H. Abdulahad2, Gerda Horst3, Abraham Rutgers2, Annemieke M.H. Boots4 and Elisabeth Brouwer5, 1Dept. of Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 2Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 3University Medical Center Groningen, Groningen, Netherlands, 4Dept. of Rheumatology and Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands, 5Hanzeplein 1, UMCG, Groningen, Netherlands

    Background/Purpose: The role of B cells in auto-immunity may extend beyond the production of auto-antibodies. B cells can influence T cell responses via antigen presentation…
  • Abstract Number: 2349 • 2012 ACR/ARHP Annual Meeting

    Corticosterois Therapy Restaured Treg/Th17 Balance in Patients with Polimyalgia Rheumatica

    Lorena Alvarez-Rodriguez1, Marcos Lopez-Hoyos2, Jaime Calvo-Alen3, Elena Aurrecoechea4, Teresa Ruiz Jimeno4, Ignacio Villa4, Carmen Gonzalez-Vela5 and Victor M. Martinez-Taboada1, 1Rheumatology, Hospital Universitario Marques de Valdecilla. IFIMAV, Santander, Spain, 2Immunology, Hospital Universitario Marques de Valdecilla. IFIMAV, Santander, Spain, 3Rheumatology, Hospital de Sierrallana. Torrelavega. Spain, Torrelavega, Spain, 4Rheumatology, Hospital de Sierrallana, Torrelavega, Spain, 5Pathology Anatomy, Hospital Universitario Marques de Valdecilla. IFIMAV, Santander, Spain

    Background/Purpose: To characterize the levels of circulating T regulatory cells (Tregs) and Th17 cells in polymyalgia rheumatica (PMR). Methods: The study included 46 patients with…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology